Therapeutic proteins immunogenicity: a peptide point of view
Protein therapeutics are extensively used in the treatment of autoimmune diseases, but a subset of patients appears to be refractory to these treatments, mainly due to the development of an immune response to the drug. A better understanding of the mechanism underlying the therapeutic drug’s failure...
Saved in:
| Main Authors: | Feliciana Real-Fernandez, Fosca Errante, Andrea Di Santo, Anna Maria Papini, Paolo Rovero |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration
2023-10-01
|
| Series: | Exploration of Drug Science |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A100825/100825.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structural information in therapeutic peptides: Emerging applications in biomedicine
by: Valentín Iglesias, et al.
Published: (2025-02-01) -
Gold Nanoparticles as a Platform for Delivery of Immunogenic Peptides to THP-1 Derived Macrophages: Insights into Nanotoxicity
by: Eduardo Zúñiga, et al.
Published: (2025-01-01) -
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
by: Belén Aparicio, et al.
Published: (2021-01-01) -
The Identification of Dual T-Cell and B-Cell Epitopes Within Viral Proteins Utilizing a Comprehensive Peptide Array Approach
by: Binghang Liu, et al.
Published: (2025-02-01) -
Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors
by: Montserrat Puig, et al.
Published: (2025-06-01)